Rune Bergman

Chief Executive Officer at Nordvacc Läkemedel AB

81 year

Consumer Services

Health Technology

Distribution Services

Profile

Rune Bergman was the founder of Intervacc AB, where he held the title of Chairman & Sales Director from 2001 to 2018.
He is currently the Chief Executive Officer at Nordvacc Läkemedel AB.
Dr. Bergman received a doctorate degree from the Swedish University of Agricultural Sciences in 1981.

Rune Bergman active positions

Companies	Position	Start
Nordvacc Läkemedel AB Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The private company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman.	Chief Executive Officer	-

All active positions of Rune Bergman

Former positions of Rune Bergman

Companies	Position	End
INTERVACC AB	Founder	30/06/2019

See the detail of Rune Bergman's experience

Training of Rune Bergman

Swedish University of Agricultural Sciences

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rune Bergman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INTERVACC AB	Health Technology

Private companies	1
Nordvacc Läkemedel AB Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The private company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman.	Distribution Services